Oxford Gene Technology at FoG London 2027

Jan 27–28, 2027 London, UK ~8.3k attendees Website

Oxford Gene Technology takes part in 1 session at FoG London 2027 in London, and exhibits at Booth 132. Its session reports a retrospective study of next-generation sequencing (NGS) for measuring minimal residual disease in acute myeloid leukaemia (AML) samples. It looks at what a broader genomic view adds to tracking residual disease.

OrganizationFoG London 2027 Attendance
◆Agenda Partner
DiagnosticsAgenda Partner
Maker of hybridisation-based genetic testing products, such as microarrays, FISH probes and NGS panels, for clinical research and diagnostic labs.
Booth
Exhibiting at Booth 132
Talk
Thu Jan 28
14:40–15:10
MRD Through a Broader Genomic Lens: Findings from a retrospective study of NGS-based MRD analysis in AML sample cohorts
How highly sensitive DNA sequencing panels could track leftover leukaemia cells in acute myeloid leukaemia samples to better judge relapse risk.

Explore the full FoG London 2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in London. Leave your work email and we’ll be in touch.

Privacy

Download the full FoG London 2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Oxford Gene Technology

Tell us what you sell and we’ll find the people at Oxford Gene Technology most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by Front Line Genomics or the Festival of Genomics. Submit a correction